Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Gabapentin Market, by Application
1.4.2 Global Gabapentin Market, by Dosage Form
1.4.3 Global Gabapentin Market, by Distribution Channel
1.4.4 Global Gabapentin Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Gabapentin Market by Application
3.1 Global Epilepsy Market by Region
3.2 Global Restless Legs Syndrome Market by Region
3.3 Global Neuropathic Pain Market by Region
3.4 Global Others Market by Region
Chapter 4. Global Gabapentin Market by Dosage Form
4.1 Global Capsule Market by Region
4.2 Global Tablet Market by Region
4.3 Global Oral Solution Market by Region
Chapter 5. Global Gabapentin Market by Distribution Channel
5.1 Global Hospital Pharmacy Market by Region
5.2 Global Retail Pharmacy Market by Region
5.3 Global Online Pharmacy Market by Region
Chapter 6. Global Gabapentin Market by Region
6.1 North America Gabapentin Market
6.1.1 North America Gabapentin Market by Application
6.1.1.1 North America Epilepsy Market by Country
6.1.1.2 North America Restless Legs Syndrome Market by Country
6.1.1.3 North America Neuropathic Pain Market by Country
6.1.1.4 North America Others Market by Country
6.1.2 North America Gabapentin Market by Dosage Form
6.1.2.1 North America Capsule Market by Country
6.1.2.2 North America Tablet Market by Country
6.1.2.3 North America Oral Solution Market by Country
6.1.3 North America Gabapentin Market by Distribution Channel
6.1.3.1 North America Hospital Pharmacy Market by Country
6.1.3.2 North America Retail Pharmacy Market by Country
6.1.3.3 North America Online Pharmacy Market by Country
6.1.4 North America Gabapentin Market by Country
6.1.4.1 US Gabapentin Market
6.1.4.1.1 US Gabapentin Market by Application
6.1.4.1.2 US Gabapentin Market by Dosage Form
6.1.4.1.3 US Gabapentin Market by Distribution Channel
6.1.4.2 Canada Gabapentin Market
6.1.4.2.1 Canada Gabapentin Market by Application
6.1.4.2.2 Canada Gabapentin Market by Dosage Form
6.1.4.2.3 Canada Gabapentin Market by Distribution Channel
6.1.4.3 Mexico Gabapentin Market
6.1.4.3.1 Mexico Gabapentin Market by Application
6.1.4.3.2 Mexico Gabapentin Market by Dosage Form
6.1.4.3.3 Mexico Gabapentin Market by Distribution Channel
6.1.4.4 Rest of North America Gabapentin Market
6.1.4.4.1 Rest of North America Gabapentin Market by Application
6.1.4.4.2 Rest of North America Gabapentin Market by Dosage Form
6.1.4.4.3 Rest of North America Gabapentin Market by Distribution Channel
6.2 Europe Gabapentin Market
6.2.1 Europe Gabapentin Market by Application
6.2.1.1 Europe Epilepsy Market by Country
6.2.1.2 Europe Restless Legs Syndrome Market by Country
6.2.1.3 Europe Neuropathic Pain Market by Country
6.2.1.4 Europe Others Market by Country
6.2.2 Europe Gabapentin Market by Dosage Form
6.2.2.1 Europe Capsule Market by Country
6.2.2.2 Europe Tablet Market by Country
6.2.2.3 Europe Oral Solution Market by Country
6.2.3 Europe Gabapentin Market by Distribution Channel
6.2.3.1 Europe Hospital Pharmacy Market by Country
6.2.3.2 Europe Retail Pharmacy Market by Country
6.2.3.3 Europe Online Pharmacy Market by Country
6.2.4 Europe Gabapentin Market by Country
6.2.4.1 Germany Gabapentin Market
6.2.4.1.1 Germany Gabapentin Market by Application
6.2.4.1.2 Germany Gabapentin Market by Dosage Form
6.2.4.1.3 Germany Gabapentin Market by Distribution Channel
6.2.4.2 UK Gabapentin Market
6.2.4.2.1 UK Gabapentin Market by Application
6.2.4.2.2 UK Gabapentin Market by Dosage Form
6.2.4.2.3 UK Gabapentin Market by Distribution Channel
6.2.4.3 France Gabapentin Market
6.2.4.3.1 France Gabapentin Market by Application
6.2.4.3.2 France Gabapentin Market by Dosage Form
6.2.4.3.3 France Gabapentin Market by Distribution Channel
6.2.4.4 Russia Gabapentin Market
6.2.4.4.1 Russia Gabapentin Market by Application
6.2.4.4.2 Russia Gabapentin Market by Dosage Form
6.2.4.4.3 Russia Gabapentin Market by Distribution Channel
6.2.4.5 Spain Gabapentin Market
6.2.4.5.1 Spain Gabapentin Market by Application
6.2.4.5.2 Spain Gabapentin Market by Dosage Form
6.2.4.5.3 Spain Gabapentin Market by Distribution Channel
6.2.4.6 Italy Gabapentin Market
6.2.4.6.1 Italy Gabapentin Market by Application
6.2.4.6.2 Italy Gabapentin Market by Dosage Form
6.2.4.6.3 Italy Gabapentin Market by Distribution Channel
6.2.4.7 Rest of Europe Gabapentin Market
6.2.4.7.1 Rest of Europe Gabapentin Market by Application
6.2.4.7.2 Rest of Europe Gabapentin Market by Dosage Form
6.2.4.7.3 Rest of Europe Gabapentin Market by Distribution Channel
6.3 Asia Pacific Gabapentin Market
6.3.1 Asia Pacific Gabapentin Market by Application
6.3.1.1 Asia Pacific Epilepsy Market by Country
6.3.1.2 Asia Pacific Restless Legs Syndrome Market by Country
6.3.1.3 Asia Pacific Neuropathic Pain Market by Country
6.3.1.4 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Gabapentin Market by Dosage Form
6.3.2.1 Asia Pacific Capsule Market by Country
6.3.2.2 Asia Pacific Tablet Market by Country
6.3.2.3 Asia Pacific Oral Solution Market by Country
6.3.3 Asia Pacific Gabapentin Market by Distribution Channel
6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
6.3.3.2 Asia Pacific Retail Pharmacy Market by Country
6.3.3.3 Asia Pacific Online Pharmacy Market by Country
6.3.4 Asia Pacific Gabapentin Market by Country
6.3.4.1 China Gabapentin Market
6.3.4.1.1 China Gabapentin Market by Application
6.3.4.1.2 China Gabapentin Market by Dosage Form
6.3.4.1.3 China Gabapentin Market by Distribution Channel
6.3.4.2 Japan Gabapentin Market
6.3.4.2.1 Japan Gabapentin Market by Application
6.3.4.2.2 Japan Gabapentin Market by Dosage Form
6.3.4.2.3 Japan Gabapentin Market by Distribution Channel
6.3.4.3 India Gabapentin Market
6.3.4.3.1 India Gabapentin Market by Application
6.3.4.3.2 India Gabapentin Market by Dosage Form
6.3.4.3.3 India Gabapentin Market by Distribution Channel
6.3.4.4 South Korea Gabapentin Market
6.3.4.4.1 South Korea Gabapentin Market by Application
6.3.4.4.2 South Korea Gabapentin Market by Dosage Form
6.3.4.4.3 South Korea Gabapentin Market by Distribution Channel
6.3.4.5 Singapore Gabapentin Market
6.3.4.5.1 Singapore Gabapentin Market by Application
6.3.4.5.2 Singapore Gabapentin Market by Dosage Form
6.3.4.5.3 Singapore Gabapentin Market by Distribution Channel
6.3.4.6 Malaysia Gabapentin Market
6.3.4.6.1 Malaysia Gabapentin Market by Application
6.3.4.6.2 Malaysia Gabapentin Market by Dosage Form
6.3.4.6.3 Malaysia Gabapentin Market by Distribution Channel
6.3.4.7 Rest of Asia Pacific Gabapentin Market
6.3.4.7.1 Rest of Asia Pacific Gabapentin Market by Application
6.3.4.7.2 Rest of Asia Pacific Gabapentin Market by Dosage Form
6.3.4.7.3 Rest of Asia Pacific Gabapentin Market by Distribution Channel
6.4 LAMEA Gabapentin Market
6.4.1 LAMEA Gabapentin Market by Application
6.4.1.1 LAMEA Epilepsy Market by Country
6.4.1.2 LAMEA Restless Legs Syndrome Market by Country
6.4.1.3 LAMEA Neuropathic Pain Market by Country
6.4.1.4 LAMEA Others Market by Country
6.4.2 LAMEA Gabapentin Market by Dosage Form
6.4.2.1 LAMEA Capsule Market by Country
6.4.2.2 LAMEA Tablet Market by Country
6.4.2.3 LAMEA Oral Solution Market by Country
6.4.3 LAMEA Gabapentin Market by Distribution Channel
6.4.3.1 LAMEA Hospital Pharmacy Market by Country
6.4.3.2 LAMEA Retail Pharmacy Market by Country
6.4.3.3 LAMEA Online Pharmacy Market by Country
6.4.4 LAMEA Gabapentin Market by Country
6.4.4.1 Brazil Gabapentin Market
6.4.4.1.1 Brazil Gabapentin Market by Application
6.4.4.1.2 Brazil Gabapentin Market by Dosage Form
6.4.4.1.3 Brazil Gabapentin Market by Distribution Channel
6.4.4.2 Argentina Gabapentin Market
6.4.4.2.1 Argentina Gabapentin Market by Application
6.4.4.2.2 Argentina Gabapentin Market by Dosage Form
6.4.4.2.3 Argentina Gabapentin Market by Distribution Channel
6.4.4.3 UAE Gabapentin Market
6.4.4.3.1 UAE Gabapentin Market by Application
6.4.4.3.2 UAE Gabapentin Market by Dosage Form
6.4.4.3.3 UAE Gabapentin Market by Distribution Channel
6.4.4.4 Saudi Arabia Gabapentin Market
6.4.4.4.1 Saudi Arabia Gabapentin Market by Application
6.4.4.4.2 Saudi Arabia Gabapentin Market by Dosage Form
6.4.4.4.3 Saudi Arabia Gabapentin Market by Distribution Channel
6.4.4.5 South Africa Gabapentin Market
6.4.4.5.1 South Africa Gabapentin Market by Application
6.4.4.5.2 South Africa Gabapentin Market by Dosage Form
6.4.4.5.3 South Africa Gabapentin Market by Distribution Channel
6.4.4.6 Nigeria Gabapentin Market
6.4.4.6.1 Nigeria Gabapentin Market by Application
6.4.4.6.2 Nigeria Gabapentin Market by Dosage Form
6.4.4.6.3 Nigeria Gabapentin Market by Distribution Channel
6.4.4.7 Rest of LAMEA Gabapentin Market
6.4.4.7.1 Rest of LAMEA Gabapentin Market by Application
6.4.4.7.2 Rest of LAMEA Gabapentin Market by Dosage Form
6.4.4.7.3 Rest of LAMEA Gabapentin Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Zydus Lifesciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and approvals:
7.2 Glenmark Pharmaceuticals Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Pfizer, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expense
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Alkem Laboratories Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Aurobindo Pharma Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Cipla Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.10. Apotex, Inc.
7.10.1 Company Overview
Unique Offerings 